Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junsheng Xue

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Pharmaceutical and Biomedical Analysis|August 8, 2020
Development and validation of a highly sensitive HPLC-MS/MS method for the QAP14, a novel potential anti-cancer agent, in rat plasma and its application to a pharmacokinetic studyYuchen Guo, Qingyu Yao, Daming Kong, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2026
Integrative QSP Modeling of Cancer Stem Cells in Triple-Negative Breast Cancer: Impacts on Tumor Immunity and Response to Immune Checkpoint InhibitorsJunsheng Xue, Weizhe Jian, Tianyu Wang, et al.
Life Sciences|August 23, 2020
Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinomaJunsheng Xue, Ye Yao, Qingyu Yao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
A Simplified Three-Tailed N-Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose-Accumulated mRNA Delivery for Anti-Obesity TherapyBin Ma, Yunxuan Liu, Huijuan Zhang, et al.
Journal of Pharmaceutical Sciences|June 23, 2020
Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI-B001, an EGFR/HER3 Bi-specific Monoclonal AntibodyJunsheng Xue, Daming Kong, Ye Yao, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 21, 2025
Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B PatientsWeizhe Jian, Yalin Yin, Rong Chen, et al.
Toxicology and Applied Pharmacology|November 1, 2019
N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activationHong Su, Zixi Xue, Yaoyao Feng, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Pharmaceutical and Biomedical Analysis|August 8, 2020
Development and validation of a highly sensitive HPLC-MS/MS method for the QAP14, a novel potential anti-cancer agent, in rat plasma and its application to a pharmacokinetic studyYuchen Guo, Qingyu Yao, Daming Kong, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2026
Integrative QSP Modeling of Cancer Stem Cells in Triple-Negative Breast Cancer: Impacts on Tumor Immunity and Response to Immune Checkpoint InhibitorsJunsheng Xue, Weizhe Jian, Tianyu Wang, et al.
Life Sciences|August 23, 2020
Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinomaJunsheng Xue, Ye Yao, Qingyu Yao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
A Simplified Three-Tailed N-Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose-Accumulated mRNA Delivery for Anti-Obesity TherapyBin Ma, Yunxuan Liu, Huijuan Zhang, et al.
Journal of Pharmaceutical Sciences|June 23, 2020
Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI-B001, an EGFR/HER3 Bi-specific Monoclonal AntibodyJunsheng Xue, Daming Kong, Ye Yao, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 21, 2025
Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B PatientsWeizhe Jian, Yalin Yin, Rong Chen, et al.
Toxicology and Applied Pharmacology|November 1, 2019
N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activationHong Su, Zixi Xue, Yaoyao Feng, et al.
Pageof 2